HIGHLIGHTS
- who: Acute Exacerbation Schizophrenia A et al. from the University of Alberta, Canada have published the article: Comparison of Ef fi cacy and Safety Between Low-Dose Ziprasidone in Combination With Sertraline and Ziprasidone Monotherapy for Treatment-Resistant Patients With Acute Exacerbation Schizophrenia: A Randomized Controlled Trial, in the Journal: (JOURNAL)
- how: In this study serotonin was used to alleviate the depressive symptoms in TRS patients. To investigate whether ziprasidone at a low dose (60-80 mg/d) in combination with sertraline is effective in the treatment of treatment-resistant patients with acute exacerbation SZ . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.